SYNOPSIS A case is described of a 73 year old male with Waldenstrom's macroglobulinaemia and hyperviscosity in association with neurological abnormalities, the Bing-Neel syndrome. The relationship of the clinical features to changes in serum viscosity and the response to therapy with plasmapheresis and chlorambucil are discussed.
In 1944 Waldenstrom described a condition characterized by excessive production of macroglobulin. Earlier, the association of hyperglobulinaemia with neurological abnormalities had been recognized (Bing and Neel, 1936; Bing et al., 1937) and a further report (Bichel et al., 1950) referred to a similar case with large amounts of macroglobulin in the serum. The combination of neurological features and macroglobulinaemia has since been referred to as the 'Bing-Neel' syndrome. We describe the first case of mononeuritis multiplex, with both cranial and peripheral nerve involvement, in a patient with this syndrome. D. M. Fraser, A. C. Parker, S. Amer, and I. W. Campbell been maintained between 2.0 and 2.3. The EEG is now normal, with complete resolution of previous changes (Fig. 1) .
DISCUSSION
The clinical picture of nervous system involvement in Waldenstrom's macroglobulinaemia is referred to as the Bing-Neel syndrome and Logothetis et al. (1960) found this in up to 25 % of patients. Central nervous system features may take the form of a focal brain syndrome, possibly associated with epilepsy, and usually secondary to haemorrhage or thrombosis. Alternatively, a diffuse encephalopathy can occur, with headache, mental changes, and impaired conscious level, the so-called 'coma paraproteinaemicum' described by Wuhrmann (1956) . Solomon (1965) has shown that the related EEG disturbance-namely, a slow, diffuse dysrhythmia-may be reversed by effective treatment, as occurred in our patient. The commonest peripheral manifestation is a symmetrical polyneuropathy of sensorimotor type, usually occurring late in the disease (McCallister et al., 1967) . Cranial neuropathies consisting of progressive deafness or facial palsy have been reported by Waldenstrom (1948) and Tischendorf and Hartmann (1950) . Glenchur et al. (1958) described a case of pure motor neuropathy, with wasting of the intrinsic muscles in both hands. However, the combination of multiple cranial and peripheral neuropathies as in our present case has not been described in Waldenstr6m's macroglobulinaemia. Solomon (1965) and Fahey et al. (1965) have postulated a direct relationship between hyperviscosity due to macroglobulinaemia and neurological involvement. The level of serum viscosity at which symptoms occur is extremely variable but the 'symptomatic threshold' is thought to lie between 6.0 and 7.0. In our patient the serum viscosity at the time of presentation was 5.9 and his symptomatic threshold appeared to be as low as 3.0 (Fig. 2) . Although the IBM continuous flow blood cell separator has been shown to be the most effective way of removing the abnormal protein (Powles et al., 1971) , this technology is not yet available in our centre and plasmapheresis was therefore carried out at monthly intervals. When the patient developed new neurological features the interval between each plasmapheresis was reduced to two weeks. Some patients undergo complete remission if plasmapheresis is combined with continuous chlorambucil (McCallister et al., 1967) . On this regimen our patient has remained free of new symptoms for almost 18 months, with a serum relative viscosity maintained below 3.0, a marked fall in serum IgM levels, and reversal of the bone marrow to normal. His cranial neuropathies have undergone complete resolution and, although there is no clinical recovery of ulnar nerve function, conduction velocity has improved in the motor fibres of the right ulnar nerve, which Payan (1970) suggests may be the first indication of functional recovery. 
